← Return to Can anyone share their experience with Pluvicto?

Discussion

Can anyone share their experience with Pluvicto?

Prostate Cancer | Last Active: Oct 22 6:00am | Replies (79)
Comment receiving replies
@smc24

Redroadtraveler,
This what is said. Norvartis Pharmaceutical completed a clinical trial (PSMA-617 Lu-177) and was approved (USFDA March 23, 2022) for one round of 6 treatments. It is now called Pluvicto. There is plenty of supporting historical and current data on the trial(s) and currect usage. After all, it was a clinical trial. It is now an approved option for metastatic castration-resistant prostate cancer. BUT, there is no data that I have found regarding REPEATING THE ENTIRE 6 ROUNDS, #7 through #12) which I just started this Sept. It was not designed for, tested or approved beyond one tound of 6 treatments. I was one of the ORIGINAL clinical trial patients 2021-2022, so I'm minutely aware of the existing data, as I am included in the findings. When rounds #7 through #12 are completed in April 2025, perhaps that new data will be released.

Jump to this post

Replies to "Redroadtraveler, This what is said. Norvartis Pharmaceutical completed a clinical trial (PSMA-617 Lu-177) and was approved..."
redroadtraveler | @redroadtraveler | Sep 28 2:02pm

Yes.

I have now completed my six rounds of Pluvicto. More Pluvicto treatments beyond six rounds puts us right back into unknown, experimental territory.

Pluvicto seems to be the current "final frontier" of treatments available from the allopathic world. As far as I know, once we have completed the initial six rounds that's the end of any FDA approved treatments. We are on our own at that point. My experience with Pluvicto has been very good. All the oncologist can offer at this point is simply continuing to monitor my condition.

If it begins to get significantly worse I will be lobbying for me to jump into the experimental world of additional Pluvicto treatments.

I wish you good luck with your additional Pluvicto treatments.

VIEW AND REPLY